Form 4: GoodRx Director Converts RSUs to Common Stock

GoodRx Holdings, Inc. Director Kelly J. Kennedy converted 23,149 restricted stock units into Class A common stock, increasing her direct beneficial ownership.

Summary

• Director Kelly J. Kennedy of GoodRx Holdings, Inc. converted 23,149 Restricted Stock Units (RSUs) into Class A Common Stock.
• This transaction occurred on December 21, 2025.
• Following the conversion, Kennedy directly beneficially owns 134,211 shares of Class A Common Stock.
• Each RSU represents a contingent right to receive one share of Class A common stock, with an exercise price of $0.
• The original RSU award vests one-third annually over three years, commencing December 21, 2024, contingent on continued service.

Sentiment

Score: 6

Explanation: The conversion of RSUs into common stock by a director is a neutral to slightly positive event, as it represents a director increasing their direct stake in the company, often seen as a sign of confidence. However, it's a pre-scheduled event related to compensation rather than a discretionary purchase.

Positives

• Increased direct ownership by a director, potentially signaling confidence in the company's future.

Future Outlook

The vesting schedule for the restricted stock units indicates a long-term retention strategy for the director, with vesting continuing through at least December 21, 2026, subject to continued service.

Industry Context

This is a routine insider transaction related to equity compensation, common across publicly traded companies to align management and director interests with shareholders. It does not provide specific insights into broader industry trends for healthcare technology or prescription discount services.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to higher direct stock ownership.
• Employees: Standard equity compensation practices are being executed.

Next Steps

• Continued vesting of remaining restricted stock units on subsequent anniversaries of the grant date (December 21, 2024).

Key Dates

Recommendation

This Form 4 reports a routine conversion of restricted stock units into common stock by a director as part of their compensation plan. While it increases the director's direct ownership, which can be seen as a minor positive for alignment, it is not a discretionary open-market purchase or sale that would typically warrant a change in investment recommendation. The transaction itself does not provide new fundamental information about the company's performance or outlook to alter an existing investment thesis.

Keywords

GoodRx Holdings, GDRX, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director Stock Ownership, Equity Compensation